Tacrolimus

  • Check with publisher
  • Published date: December 24, 2019
    • Shirley, New York, United States

Tacrolimus is a calcineurin inhibitor immunosuppressant used for the treatment of patients with graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). https://www.bocsci.com/tacrolimus-cas-104987-11-3-item-482829.html

Result 0 votes
Alex Brown
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Vorinostat

    Vorinostat

    Cell Biology & Microbiology Shirley (New York) December 24, 2019 Check with publisher

    Vorinostat, a HDAC inhibitor, has been found to exhibit anti-angiogenic activity and could induce differentiation in breast cancer cells. https://www.bocsci.com/vorinostat-cas-149647-78-9-item-485286.html

  • Azacitidine

    Azacitidine

    Cell Biology & Microbiology Shirley (New York) December 24, 2019 Check with publisher

    Azacitidine is a potent growth inhibitor and a cytotoxic agent. It acts as a demethylating agent by inhibiting DNA methyltransferase (Dnmt), forming covalent adducts with cellular DNMT1 depleting enzyme activity. It also improves the efficiency of re...

  • Tranylcipromine

    Tranylcipromine

    Cell Biology & Microbiology Shirley (New York) December 24, 2019 Check with publisher

    Tranylcipromine inhibits Lysine-Specific Demethylase 1 (LSD1, IC50 = 20.7 µM), MAO A (IC50 = 2.3 µM) and MAO B (IC50 = 0.95 µM). This compound has been demonstrated that it promoted reprogramming of mouse embryonic fibroblasts to induced pluripotent ...